Herbal medicines and nonalcoholic fatty liver disease

World Journal of Gastroenterology

Volumn 22, Issue 30, 2016, Pages 6890-6905

  Yao, Hong ^a   Qiao, Yu Jie ^a   Zhao, Ya Li ^a   Tao, Xu Feng ^a   Xu, Li Na ^a   Yin, Lian Hong ^a   Qi, Yan ^a   Peng, Jin Yong ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Herbal medicines; Natural product; Nonalcoholic fatty liver disease; Review; Traditional Chinese medicines

Indexed keywords

APIGENIN; ARTEMISININ; AURANTIIN; BAICALIN; BLUEBERRY EXTRACT; CURCUMIN; CYANIDIN 3 GLUCOSIDE; ELLAGIC ACID; FLAVONOID; GENISTEIN; GENTIOPICRIN; GINSENOSIDE RB 1; GINSENOSIDE RG 1; HIBISCUS SABDARIFFA EXTRACT; ISORHAMNETIN; KAEMPFEROL; LUTEOLIN; MYRICETIN; PINOCEMBRINE; POLYPHENOL; PUERARIN; QUERCETIN; RESVERATROL; RUTAECARPINE; RUTOSIDE; SALVIANOLIC ACID B; SHIKONIN; SILIBININ; UNINDEXED DRUG; URSOLIC ACID; HERBACEOUS AGENT; PLANT EXTRACT; SAPONIN;

APOPTOSIS; ASPALATHUS LINEARIS; CACAO; CEREAL; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; CHINESE HERB; COFFEE; CURCUMA LONGA; DRUG FORMULATION; DRUG MECHANISM; FRUCTUS MORI; GINSENG; GLYCYRRHIZA URALENSIS; HERBAL MEDICINE; HUMAN; LIVER PROTECTION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PEANUT; PLANT LEAF; PLANT ROOT; POLYGALA TENUIFOLIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RED WINE; REVIEW; SYSTEMATIC REVIEW; TEA; CHINESE MEDICINE; NON-ALCOHOLIC FATTY LIVER DISEASE; PHYTOTHERAPY;

DRUGS, CHINESE HERBAL; FLAVONOIDS; HERBAL MEDICINE; HUMANS; MEDICINE, CHINESE TRADITIONAL; NON-ALCOHOLIC FATTY LIVER DISEASE; PHYTOTHERAPY; PLANT EXTRACTS; SAPONINS;

EID: 84982102632     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i30.6890     Document Type: Review

References (171)

1. Schuppan D, Gorrell MD, Klein T, Mark M, Afdhal NH. The challenge of developing novel pharmacological therapies for nonalcoholic steatohepatitis. Liver Int 2010; 30: 795-808 [PMID: 20624207 DOI: 10.1111/j.1478-3231.2010.02264.x]
2. Stojsavljevic S, Gomercic Palcic M, Virovic Jukic L, Smircic Duvnjak L, Duvnjak M. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20: 18070-18091 [PMID: 25561778 DOI: 10.3748/wjg.v20.i48.18070]
3. Byrne CD, Targher G. NAFLD: A multisystem disease. J Hepatol 2015; 62: S47-S64 [PMID: 25920090 DOI: 10.1016/j.jhep.2014.12.012]
4. Bhatia LS, Curzen NP, Calder PC, Byrne CD. Non-alcoholic fatty liver disease: A new and important cardiovascular risk factor? Eur Heart J 2012; 33: 1190-1200 [PMID: 22408036 DOI: 10.1093/eurheartj/ehr453]
5. Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 2009; 50: 204-210 [PMID: 19014878 DOI: 10.1016/j.jhep.2008.10.010]
6. Vajro P, Lenta S, Pignata C, Salerno M, D'Aniello R, De Micco I, Paolella G, Parenti G. Therapeutic options in pediatric non alcoholic fatty liver disease: Current status and future directions. Ital J Pediatr 2012; 38: 55 [PMID: 23075296 DOI: 10.1186/1824-7288-38-55]
7. Tziomalos K, Athyros VG, Paschos P, Karagiannis A. Nonalcoholic fatty liver disease and statins. Metabolism 2015; 64: 1215-1223 [PMID: 26234727 DOI: 10.1016/j.metabol.2015.07.003]
8. Gu Y, Lambert JD. Modulation of metabolic syndrome-related inflammation by cocoa. Mol Nutr Food Res 2013; 57: 948-961 [PMID: 23637048 DOI: 10.1002/mnfr.201200837]
9. Dahlhoff C, Worsch S, Sailer M, Hummel BA, Fiamoncini J, Uebel K, Obeid R, Scherling C, Geisel J, Bader BL, Daniel H. Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acylcarnitine levels. Mol Metab 2014; 3: 565-580 [PMID: 25061561 DOI: 10.1016/j.molmet.2014.04.010]
10. Day CP. Non-alcoholic fatty liver disease: A massive problem. Clin Med (Lond) 2011; 11: 176-178 [PMID: 21526706]
11. Zelber-Sagi S, Lotan R, Shlomai A, Webb M, Harrari G, Buch A, Nitzan Kaluski D, Halpern Z, Oren R. Predictors for incidence and remission of NAFLD in the general population during a seven- year prospective follow-up. J Hepatol 2012; 56: 1145-1151 [PMID: 22245895 DOI: 10.1016/j.jhep.2011.12.011]
12. Haga Y, Kanda T, Sasaki R, Nakamura M, Nakamoto S, Yokosuka O. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis. World J Gastroenterol 2015; 21: 12989-12995 [PMID: 26675364 DOI: 10.3748/wjg.v21.i46]
13. Jacome-Sosa MM, Borthwick F, Mangat R, Uwiera R, Reaney MJ, Shen J, Quiroga AD, Jacobs RL, Lehner R, Proctor SD, Nelson RC. Diets enriched in trans-11 vaccenic acid alleviate ectopic lipid accumulation in a rat model of NAFLD and metabolic syndrome. J Nutr Biochem 2014; 25: 692-701 [PMID: 24775093 DOI: 10.1016/j.jnutbio.2014.02.011]
14. Karlas T, Wiegand J, Berg T. Gastrointestinal complications of obesity: Non-alcoholic fatty liver disease (NAFLD) and its sequelae. Best Pract Res Clin Endocrinol Metab 2013; 27: 195-208 [PMID: 23731881 DOI: 10.1016/j.beem.2013.02.002]
15. Li Y, Zhao J, Zheng H, Zhong X, Zhou J, Hong Z. Treatment of Nonalcoholic Fatty Liver Disease with Total Alkaloids in Rubus aleaefolius Poir through Regulation of Fat Metabolism. Evid Based Complement Alternat Med 2014; 2014: 768540 [PMID: 25404949 DOI: 10.1155/2014/768540]
16. Liu X, Gao Y, Li M, Geng C, Xu H, Yang Y, Guo Y, Jiao T, Fang F, Chang Y. Sirt1 mediates the effect of the heme oxygenase inducer, cobalt protoporphyrin, on ameliorating liver metabolic damage caused by a high-fat diet. J Hepatol 2015; 63: 713-721 [PMID: 26026874 DOI: 10.1016/j.jhep.2015.05.018]
17. Martínez-Uña M, Varela-Rey M, Mestre D, Fernández-Ares L, Fresnedo O, Fernandez-Ramos D, Gutiérrez-de Juan V, Martin- Guerrero I, García-Orad A, Luka Z, Wagner C, Lu SC, García- Monzón C, Finnell RH, Aurrekoetxea I, Buqué X, Martínez- Chantar ML, Mato JM, Aspichueta P. S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in nonalcoholic fatty liver disease. J Hepatol 2015; 62: 673-681 [PMID: 25457203 DOI: 10.1016/j.jhep.2014.10.019]
18. Maslak E, Gregorius A, Chlopicki S. Liver sinusoidal endothelial cells (LSECs) function and NAFLD; NO-based therapy targeted to the liver. Pharmacol Rep 2015; 67: 689-694 [PMID: 26321269 DOI: 10.1016/j.pharep.2015.04.010]
19. McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM. Evidence of NAFLD progression from steatosis to fibrosingsteatohepatitis using paired biopsies: Implications for prognosis and clinical management. J Hepatol 2015; 62: 1148-1155 [PMID: 25477264 DOI: 10.1016/j.jhep.2014.11.034]
20. Muñoz M, Sánchez A, Pilar Martínez M, Benedito S, López- Oliva ME, García-Sacristán A, Hernández M, Prieto D. COX-2 is involved in vascular oxidative stress and endothelial dysfunction of renal interlobar arteries from obese Zucker rats. Free Radic Biol Med 2015; 84: 77-90 [PMID: 25841778 DOI: 10.1016/j.freeradbio med.2015.03.024]
21. Nobili V, Svegliati-Baroni G, Alisi A, Miele L, Valenti L, Vajro P. A 360-degree overview of paediatric NAFLD: Recent insights. J Hepatol 2013; 58: 1218-1229 [PMID: 23238106 DOI: 10.1016/j.jhep.2012.12.003]
22. Pawlak M, Lefebvre P, Staels B. Molecular mechanism of PPARa action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. J Hepatol 2015; 62: 720-733 [PMID: 25450203 DOI: 10.1016/j.jhep.2014.10.039]
23. Popov VB, Lim JK. Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss. J Clin Transl Hepatol 2015; 3: 230-238 [PMID: 26623270 DOI: 10.14218/JCTH.2015.00019]
24. Ford RJ, Fullerton MD, Pinkosky SL, Day EA, Scott JW, Oakhill JS, Bujak AL, Smith BK, Crane JD, Blümer RM, Marcinko K, Kemp BE, Gerstein HC, Steinberg GR. Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity. Biochem J 2015; 468: 125-132 [PMID: 25742316 DOI: 10.1042/BJ20150125]
25. Choi Y, Yanagawa Y, Kim S, Park T. Involvement of SIRT1- AMPK signaling in the protective action of indole-3-carbinol against hepatic steatosis in mice fed a high-fat diet. J Nutr Biochem 2013; 24: 1393-1400 [PMID: 23337346 DOI: 10.1016/j.jnutbio.2012.11.007]
26. Yan F, Wang Q, Xu C, Cao M, Zhou X, Wang T, Yu C, Jing F, Chen W, Gao L, Zhao J. Peroxisome proliferator-activated receptor a activation induces hepatic steatosis, suggesting an adverse effect. PLoS One 2014; 9: E99245 [PMID: 24926685 DOI: 10.1371/journal.pone.0099245]
27. Rodriguez-Ramiro I, Vauzour D, Minihane AM. Polyphenols and non-alcoholic fatty liver disease: Impact and mechanisms. Proc Nutr Soc 2016; 75: 47-60 [PMID: 26592314]
28. Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall HU, Bamberg K, Angelin B, Hyötyläinen T, Orešic M, Bäckhed F. Gut microbiota regulates bile acid metabolism by reducing the levels of taurobeta- muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013; 17: 225-235 [PMID: 23395169 DOI: 10.1016/j.cmet.2013.01.003]
29. Shin SY, Kim TH, Wu H, Choi YH, Kim SG. SIRT1 activation by methylene blue, a repurposed drug, leads to AMPK-mediated inhibition of steatosis and steatohepatitis. Eur J Pharmacol 2014; 727: 115-124 [PMID: 24486702 DOI: 10.1016/j.ejphar.2014.01.035]
30. Wang X, Hai C. Redox modulation of adipocyte differentiation: Hypothesis of "Redox Chain" and novel insights into intervention of adipogenesis and obesity. Free Radic Biol Med 2015; 89: 99-125 [PMID: 26187871 DOI: 10.1016/j.freeradbiomed.2015.07.012]
31. Woo S, Yoon M, Kim J, Hong Y, Kim MY, Shin SS, Yoon M. The anti-angiogenic herbal extract from Melissa officinalis inhibits adipogenesis in 3T3-L1 adipocytes and suppresses adipocyte hypertrophy in high fat diet-induced obese C57BL/6J mice. J Ethnopharmacol 2016; 178: 238-250 [PMID: 26702505 DOI: 10.1016/j.jep.2015.12.015]
32. Zhang JG, Liu Q, Liu ZL, Li L, Yi LT. Antihyperglycemic activity of Anoectochilus roxburghii polysaccharose in diabetic mice induced by high-fat diet and streptozotocin. J Ethnopharmacol 2015; 164: 180-185 [PMID: 25660333 DOI: 10.1016/j.jep.2015.01.050]
33. Xia W, Sun C, Zhao Y, Wu L. Hypolipidemic and antioxidant activities of sanchi (radix notoginseng) in rats fed with a high fat diet. Phytomedicine 2011; 18: 516-520 [PMID: 21036582 DOI: 10.1016/j.phymed.2010.09.007]
34. Yuan L, Bambha K. Bile acid receptors and nonalcoholic fatty liver disease. World J Hepatol 2015; 7: 2811-2818 [PMID: 26668692 DOI: 10.4254/wjh.v7.i28.2811]
35. Xu X, Lu L, Dong Q, Li X, Zhang N, Xin Y, Xuan S. Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis. Lipids Health Dis 2015; 14: 158 [PMID: 26631018 DOI: 10.1186/s12944-015-0141-z]
36. Yang Y, Li W, Liu Y, Sun Y, Li Y, Yao Q, Li J, Zhang Q, Gao Y, Gao L, Zhao J. Alpha-lipoic acid improves high-fat diet-induced hepatic steatosis by modulating the transcription factors SREBP-1, FoxO1 and Nrf2 via the SIRT1/LKB1/AMPK pathway. J Nutr Biochem 2014; 25: 1207-1217 [PMID: 25123628 DOI: 10.1016/j.jnutbio.2014.06.001]
37. Dong SH, Zhang JF, Tang YM, Li J, Xiang YR, Liang QL. Chemical constituents from the tubers of Scirpus yagara and their anti-inflammatory activities. J Asian Nat Prod Res 2016; 18: 791-797 [PMID: 26959960]
38. Li Y, Wang X, He H, Zhang D, Jiang Y, Yang X, Wang F, Tang Z, Song X, Yue Z. Steroidal Saponins from the Roots and Rhizomes of Tupistra chinensis. Molecules 2015; 20: 13659-13669 [PMID: 26225948 DOI: 10.3390/molecules200813659]
39. Deng X, Zhang Y, Jiang F, Chen R, Peng P, Wen B, Liang J. The Chinese herb-derived Sparstolonin B suppresses HIV-1 transcription. Virol J 2015; 12: 108 [PMID: 26206295 DOI: 10.1186/s12985-015-0339-8]
40. He Y, Gai Y, Wu X, Wan H. Quantitatively analyze composition principle of Ma Huang Tang by structural equation modeling. J Ethnopharmacol 2012; 143: 851-858 [PMID: 22925947 DOI: 10.1016/j.jep.2012.08.010]
41. Gao R, Li S, Chen XJ, Wang XF, Wang SX, Fang MF. [Pharmacokinetic effect of combined administration on spinosin and ferulic acid in monarch drug Ziziphi Spinosae Semen kernel]. Zhongguo Zhong Yao Zazhi 2015; 40: 3293-3297 [PMID: 26790310]
42. Zhao L, Li W, Li Y, Xu H, Lv L, Wang X, Chai Y, Zhang G. Simultaneous Determination of Oleanolic and Ursolic Acids in Rat Plasma by HPLC-MS: Application to a Pharmacokinetic Study After Oral Administration of Different Combinations of QingGanSanJie Decoction Extracts. J Chromatogr Sci 2015; 53: 1185-1192 [PMID: 25662965 DOI: 10.1093/chromsci/bmu217]
43. Yu JC, Han YY, Cheng HY, Zhang XZ, Zhao L, Kan BH, Jia YJ, Han JX. [Combination of acupoints based on the theory of qi tonification, blood regulation and strengthening the primary source]. Zhongguo Zhen Jiu 2011; 31: 814-816 [PMID: 21972634]
44. Wu L, Zhou PQ, Xie JW, Zhu R, Zhou SC, Wang G, Wu ZX, Hao S. Effects of Yinchenhao decoction on self-regulation of reninangiotensin system by targeting angiotensin converting enzyme 2 in bile duct-ligated rat liver. J Huazhong Univ Sci Technolog Med Sci 2015; 35: 519-524 [PMID: 26223920 DOI: 10.1007/s11596-015-1463-9]
45. Lee TY, Chang HH, Lo WC, Lin HC. Alleviation of hepatic oxidative stress by Chinese herbal medicine Yin-Chen-Hao-Tang in obese mice with steatosis. Int J Mol Med 2010; 25: 837-844 [PMID: 20428786]
46. Zhou HB, Chen JM, Shao LM, Chen ZG. Apoptosis of human pancreatic carcinoma cell-1 cells induced by Yin Chen Hao Decoction. World J Gastroenterol 2015; 21: 8352-8357 [PMID: 26217086 DOI: 10.3748/wjg.v21.i27.8352]
47. Li HS, Feng Q, Hu YY. [Effect of qushl huayu decoction on highfat diet induced hepatic lipid deposition in rate]. Zhongguo Zhong Xi Yi Jie He Zazhi 2009; 29: 1092-1095 [PMID: 20214330]
48. Zhang H, Feng Q, Li HS, Chen SD, Wang XN, Peng JH, Zhang N, Hu YY. [Effects of Qushi Huayu Decoction on cathepsin B and tumor necrosis factor-alpha expression in rats with non-alcoholic steatohepatitis]. Zhong Xi Yi Jie He Xuebao 2008; 6: 928-933 [PMID: 18782536 DOI: 10.3736/jcim20080910]
49. Li HS, Feng Q, Xu LL, Chen SD, Li XM, Hu YY. [Effects of Qushi Huayu Decoction in prevention and treatment of fatty liver in rats based on adiponectin-free fatty acid pathway]. Zhong Xi Yi Jie He Xuebao 2009; 7: 546-551 [PMID: 19583937 DOI: 10.3736/jcim20090610]
50. Zhang H, Hu YY, Feng Q. [Inhibitory effects of Qushi Huayu Decoction on fatty deposition and tumor necrosis factor alpha secretion in HepG2 cells induced by free fatty acid]. Zhongguo Zhong Xi Yi Jie He Zazhi 2007; 27: 1105-1109 [PMID: 18198645]
51. Fan JG. Evaluating the efficacy and safety of Danning Pian in the short-term treatment of patients with non-alcoholic fatty liver disease: A multicenter clinical trial. Hepatobiliary Pancreat Dis Int 2004; 3: 375-380 [PMID: 15313672]
52. Zhang Q, Zhao Y, Zhang DB, Sun LJ. Effect of Sinai san decoction on the development of non-alcoholic steatohepatitis in rats. World J Gastroenterol 2005; 11: 1392-1395 [PMID: 15761983]
53. Wang N, Dong H, Wei S, Lu F. Application of proton magnetic resonance spectroscopy and computerized tomography in the diagnosis and treatment of nonalcoholic fatty liver disease. J Huazhong Univ Sci Technolog Med Sci 2008; 28: 295-298 [PMID: 18563327 DOI: 10.1007/s11596-008-0315-2]
54. Tao W, Deqin Z, Yuhong L, Hong L, Zhanbiao L, Chunfeng Z, Limin H, Xiumei G. Regulation effects on abnormal glucose and lipid metabolism of TZQ-F, a new kind of Traditional Chinese Medicine. J Ethnopharmacol 2010; 128: 575-582 [PMID: 20123010 DOI: 10.1016/j.jep.2010.01.044]
55. Tang W, Zeng L, Yin J, Yao Y, Feng L, Yao X, Sun X, Zhou B. Hugan Qingzhi Exerts Anti-Inflammatory Effects in a Rat Model of Nonalcoholic Fatty Liver Disease. Evid Based Complement Alternat Med 2015; 2015: 810369 [PMID: 26146507 DOI: 10.1155/2015/810369]
56. Ma Y, Zhao J, Yang S, Jia Y. [Cigu Xiaozhi pills's influence on lipid peroxidation and TNF-alpha expression in liver tissues of rats with nonalcoholic steatohepatitis]. Zhongguo Zhong Yao Zazhi 2010; 35: 1292-1297 [PMID: 20707200]
57. Liu HK, Hung TM, Huang HC, Lee IJ, Chang CC, Cheng JJ, Lin LC, Huang C. Bai-Hu-Jia-Ren-Shen-Tang Decoction Reduces Fatty Liver by Activating AMP-Activated Protein Kinase In Vitro and In Vivo. Evid Based Complement Alternat Med 2015; 2015: 651734 [PMID: 26508982 DOI: 10.1155/2015/651734]
58. Jiang Y, Chen L, Wang H, Narisi B, Chen B. Li-Gan-Shi-Liu- Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress. J Ethnopharmacol 2015; 176: 499-507 [PMID: 26571089 DOI: 10.1016/j.jep.2015.11.019]
59. Wang YL, Liu LJ, Zhao WH, Li JX. Intervening TNF-A via PPAR? with Gegenqinlian Decoction in Experimental Nonalcoholic Fatty Liver Disease. Evid Based Complement Alternat Med 2015; 2015: 715638 [PMID: 26221176 DOI: 10.1155/2015/715638]
60. Yuanyuan W, Minghua J, Lina Z, Suhua L, Jiayu Z, Yongzhi S, Chunyu C, Jian Q. Effect of a combination of calorie-restriction therapy and Lingguizhugan decoction on levels of fasting blood lipid and inflammatory cytokines in a high-fat diet induced hyperlipidemia rat model. J Tradit Chin Med 2015; 35: 218-221 [PMID: 25975056]
61. Li T, Han JY, Wang BB, Chen B, Li YM, Yu ZJ, Xue X, Zhang JP, Wang XB, Zeng H, Ma YL. [Huanglian jiedu decoction regulated and controlled differentiation of monocytes, macrophages, and foam cells: An experimental study]. Zhongguo Zhong Xi Yi Jie He Zazhi 2014; 34: 1096-1102 [PMID: 25335334]
62. Xie H, Zhang H, Cao K, He P, Dai H, He S. Analysis of antiasthmatic drug patents published in China between 2004 and 2013. Expert Opin Ther Pat 2016; 26: 363-376 [PMID: 26742645 DOI: 10.1517/13543776.2016.1136289]
63. Hu SC, Lee IT, Yen MH, Lin CC, Lee CW, Yen FL. Antimelanoma activity of Bupleurum chinense, Bupleurum kaoi and nanoparticle formulation of their major bioactive compound saikosaponin-d. J Ethnopharmacol 2016; 179: 432-442 [PMID: 26748071 DOI: 10.1016/j.jep.2015.12.058]
64. Wu H, She S, Liu Y, Xiong W, Guo Y, Fang H, Chen H, Li J. Protective effect of Sijunzi decoction on neuromuscular junction ultrastructure in autoimmune myasthenia gravis rats. J Tradit Chin Med 2013; 33: 669-673 [PMID: 24660594]
65. Liang B, Wei W, Wang J, Zhang M, Xu R, Wu F, Xiao H, Tang L. Protective effects of Semiaquilegia adoxoides n-butanol extract against hydrogen peroxide-induced oxidative stress in human lens epithelial cells. Pharm Biol 2016; Epub ahead of print [PMID: 26974044]
66. Chen Y, Xian Y, Lai Z, Loo S, Chan WY, Lin ZX. Antiinflammatory and anti-allergic effects and underlying mechanisms of Huang-Lian-Jie-Du extract: Implication for atopic dermatitis treatment. J Ethnopharmacol 2016; 185: 41-52 [PMID: 26976763 DOI: 10.1016/j.jep.2016.03.028]
67. Dong J, Liu S, Zhu XL, Zhang XT, Jiang Y. [Ti-AI intermetallic compound membrane refining Chinese medicinal materials extract]. Zhong Yao Cai 2014; 37: 1673-1675 [PMID: 25857171]
68. Santamarina AB, Oliveira JL, Silva FP, Carnier J, Mennitti LV, Santana AA, de Souza GH, Ribeiro EB, Oller do Nascimento CM, Lira FS, Oyama LM. Green Tea Extract Rich in Epigallocatechin- 3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High-Fat Diet. PLoS One 2015; 10: E0141227 [PMID: 26536464 DOI: 10.1371/journal.pone.0141227]
69. Nair VY, Balakrishanan N, Antony Santiago JV. Petroselinum crispum extract attenuates hepatic steatosis in rats fed with fructose enriched diet. Bratisl Lek Listy 2015; 116: 547-553 [PMID: 26435020]
70. Kuo YC, Sun CM, Ou JC, Tsai WJ. A tumor cell growth inhibitor from Polygonum hypoleucum Ohwi. Life Sci 1997; 61: 2335-2344 [PMID: 9408056]
71. Chen CH, Chang MY, Lin YS, Lin DG, Chen SW, Chao PM. A herbal extract with acetyl-coenzyme A carboxylase inhibitory activity and its potential for treating metabolic syndrome. Metabolism 2009; 58: 1297-1305 [PMID: 19500808 DOI: 10.1016/j.metabol.2009.04.012]
72. Mao J, DeMayo FJ, Li H, Abu-Elheiga L, Gu Z, Shaikenov TE, Kordari P, Chirala SS, Heird WC, Wakil SJ. Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. Proc Natl Acad Sci USA 2006; 103: 8552-8557 [PMID: 16717184]
73. Savage DB, Choi CS, Samuel VT, Liu ZX, Zhang D, Wang A, Zhang XM, Cline GW, Yu XX, Geisler JG, Bhanot S, Monia BP, Shulman GI. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl- CoA carboxylases 1 and 2. J Clin Invest 2006; 116: 817-824 [PMID: 16485039]
74. Chao PM, Kuo YH, Lin YS, Chen CH, Chen SW, Kuo YH. The metabolic benefits of Polygonum hypoleucum Ohwi in HepG2 cells and Wistar rats under lipogenic stress. J Agric Food Chem 2010; 58: 5174-5180 [PMID: 20230058 DOI: 10.1021/jf100046h]
75. Fintini D, Chinali M, Cafiero G, Esposito C, Giordano U, Turchetta A, Pescosolido S, Pongiglione G, Nobili V. Early left ventricular abnormality/dysfunction in obese children affected by NAFLD. Nutr Metab Cardiovasc Dis 2014; 24: 72-74 [PMID: 24119987 DOI: 10.1016/j.numecd.2013.06.005]
76. Yuan HD, Yuan HY, Chung SH, Jin GZ, Piao GC. An active part of Artemisia sacrorum Ledeb. Attenuates hepatic lipid accumulation through activating AMP-activated protein kinase in human HepG2 cells. Biosci Biotechnol Biochem 2010; 74: 322-328 [PMID: 20139613]
77. Liu Y, Wang D, Zhang D, Lv Y, Wei Y, Wu W, Zhou F, Tang M, Mao T, Li M, Ji B. Inhibitory effect of blueberry polyphenolic compounds on oleic acid-induced hepatic steatosis in vitro. J Agric Food Chem 2011; 59: 12254-12263 [PMID: 21999238 DOI: 10.1021/jf203136j]
78. Lee CH, Kuo CY, Wang CJ, Wang CP, Lee YR, Hung CN, Lee HJ. A polyphenol extract of Hibiscus sabdariffa L. Ameliorates acetaminophen-induced hepatic steatosis by attenuating the mitochondrial dysfunction in vivo and in vitro. Biosci Biotechnol Biochem 2012; 76: 646-651 [PMID: 22484925]
79. Aoun M, Michel F, Fouret G, Casas F, Jullien M, Wrutniak- Cabello C, Ramos J, Cristol JP, Coudray C, Carbonneau MA, Feillet-Coudray C. A polyphenol extract modifies quantity but not quality of liver fatty acid content in high-fat-high-sucrose diet-fed rats: Possible implication of the sirtuin pathway. Br J Nutr 2010; 104: 1760-1770 [PMID: 20673376 DOI: 10.1017/S00071145100]
80. Park HJ, Jung UJ, Lee MK, Cho SJ, Jung HK, Hong JH, Park YB, Kim SR, Shim S, Jung J, Choi MS. Modulation of lipid metabolism by polyphenol-rich grape skin extract improves liver steatosis and adiposity in high fat fed mice. Mol Nutr Food Res 2013; 57: 360-364 [PMID: 23109491 DOI: 10.1002/mnfr.201200447]
81. Vitaglione P, Morisco F, Mazzone G, Amoruso DC, Ribecco MT, Romano A, Fogliano V, Caporaso N, D'Argenio G. Coffee reduces liver damage in a rat model of steatohepatitis: The underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 2010; 52: 1652-1661 [PMID: 21038411 DOI: 10.1002/hep.23902]
82. Beltrán-Debón R, Rull A, Rodríguez-Sanabria F, Iswaldi I, Herranz-López M, Aragonès G, Camps J, Alonso-Villaverde C, Menéndez JA, Micol V, Segura-Carretero A, Joven J. Continuous administration of polyphenols from aqueous rooibos (Aspalathus linearis) extract ameliorates dietary-induced metabolic disturbances in hyperlipidemic mice. Phytomedicine 2011; 18: 414-424 [PMID: 21211952 DOI: 10.1016/j.phymed.2010.11.008]
83. Tsuruta Y, Nagao K, Kai S, Tsuge K, Yoshimura T, Koganemaru K, Yanagita T. Polyphenolic extract of lotus root (edible rhizome of Nelumbo nucifera) alleviates hepatic steatosis in obese diabetic db/db mice. Lipids Health Dis 2011; 10: 202 [PMID: 22067945 DOI: 10.1186/1476-511X-10-202]
84. Li Z, Xu J, Zheng P, Xing L, Shen H, Yang L, Zhang L, Ji G. Hawthorn leaf flavonoids alleviate nonalcoholic fatty liver disease by enhancing the adiponectin/AMPK pathway. Int J Clin Exp Med 2015; 8: 17295-17307 [PMID: 26770322]
85. Luo Y, Dong X, Yu Y, Sun G, Sun X. Total aralosides of aralia elata (Miq) seem (TASAES) ameliorate nonalcoholic steatohepatitis by modulating IRE1a-mediated JNK and NF-?B pathways in ApoE-/- mice. J Ethnopharmacol 2015; 163: 241-250 [PMID: 25655997 DOI: 10.1016/j.jep.2015.01.017]
86. Zhou C, Zhou J, Han N, Liu Z, Xiao B, Yin J. Beneficial effects of neomangiferin on high fat diet-induced nonalcoholic fatty liver disease in rats. Int Immunopharmacol 2015; 25: 218-228 [PMID: 25661699 DOI: 10.1016/j.intimp.2015.01.027]
87. Deng JN, Li J, Mu HN, Liu YY, Wang MX, Pan CS, Fan JY, Ye F, Han JY. Deepure Tea Improves High Fat Diet-Induced Insulin Resistance and Nonalcoholic Fatty Liver Disease. Evid Based Complement Alternat Med 2015; 2015: 980345 [PMID: 26504484 DOI: 10.1155/2015/980345]
88. Zhai L, Shi J, Xu W, Heinrich M, Wang J, Deng W. Ex Vivo and In Situ Evaluation of 'Dispelling-Wind' Chinese Medicine Herb- Drugs on Intestinal Absorption of Chlorogenic Acid. Phytother Res 2015; 29: 1974-1981 [PMID: 26514546 DOI: 10.1002/ptr.5492]
89. Sun S, Li H, Zhou W, Liu A, Zhu H. Bacterial Quorum Sensing Inhibition Activity of the Traditional Chinese Herbs, Ficus carica L. and Perilla frutescens. Chemotherapy 2014; 60: 379-383 [PMID: 26496663 DOI: 10.1159/000440946]
90. Leung PC, Ko EC, Siu WS, Pang ES, Lau CB. Selected Topical Agents Used in Traditional Chinese Medicine in the Treatment of Minor Injuries- A Review. Front Pharmacol 2016; 7: 16 [PMID: 26903864 DOI: 10.3389/fphar.2016.00016]
91. Xu Y, Zhang M, Wu T, Dai S, Xu J, Zhou Z. The anti-obesity effect of green tea polysaccharides, polyphenols and caffeine in rats fed with a high-fat diet. Food Funct 2015; 6: 297-304 [PMID: 25431018 DOI: 10.1039/c4fo00970c]
92. Zhang D, Liu L, Jia Z, Yao X, Yang M. Flavonoids of Herba Epimedii stimulate osteogenic differentiation and suppress adipogenic differentiation of primary mesenchymal stem cells via estrogen receptor pathway. Pharm Biol 2016; 54: 954-963 [PMID: 26453492 DOI: 10.3109/13880209.2015.1079224]
93. Zhang TT, Yang L, Jiang JG. Bioactive comparison of main components from unripe fruits of Rubus chingii Hu and identification of the effective component. Food Funct 2015; 6: 2205-2214 [PMID: 26053738 DOI: 10.1039/c5fo00406c]
94. Wang Y, Li JY, Han M, Wang WL, Li YZ. Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats. Lipids Health Dis 2015; 14: 85 [PMID: 26242978 DOI: 10.1186/s12944-015-0082-6]
95. Qin N, Chen Y, Jin MN, Zhang C, Qiao W, Yue XL, Duan HQ, Niu WY. Anti-obesity and anti-diabetic effects of flavonoid derivative (Fla-CN) via microRNA in high fat diet induced obesity mice. Eur J Pharm Sci 2016; 82: 52-63 [PMID: 26598088 DOI: 10.1016/j.ejps.2015.11.013]
96. Kim CS, Kwon Y, Choe SY, Hong SM, Yoo H, Goto T, Kawada T, Choi HS, Joe Y, Chung HT, Yu R. Quercetin reduces obesityinduced hepatosteatosis by enhancing mitochondrial oxidative metabolism via heme oxygenase-1. Nutr Metab (Lond) 2015; 12: 33 [PMID: 26445592 DOI: 10.1186/s12986-015-0030-5]
97. Mohan SK, Veeraraghavan VP, Jainu M. Effect of pioglitazone, quercetin and hydroxy citric acid on extracellular matrix components in experimentally induced non-alcoholic steatohepatitis. Iran J Basic Med Sci 2015; 18: 832-836 [PMID: 26557974]
98. Pisonero-Vaquero S, Martínez-Ferreras A, García-Mediavilla MV, Martínez-Flórez S, Fernández A, Benet M, Olcoz JL, Jover R, González-Gallego J, Sánchez-Campos S. Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease. Mol Nutr Food Res 2015; 59: 879-893 [PMID: 25712622 DOI: 10.1002/mnfr.2014]
99. Panchal SK, Poudyal H, Arumugam TV, Brown L. Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat dietfed rats. J Nutr 2011; 141: 1062-1069 [PMID: 21508207 DOI: 10.3945/jn.111.137877]
100. Ok HM, Gebreamanuel MR, Oh SA, Jeon H, Lee WJ, Kwon O. A Root-Based Combination Supplement Containing Pueraria lobata and Rehmannia glutinosa and Exercise Preserve Bone Mass in Ovariectomized Rats Fed a High-Fat Diet. Calcif Tissue Int 2015; 97: 624-633 [PMID: 26319677 DOI: 10.1007/s00223-015-0057-7]
101. Fu Y, Luo J, Jia Z, Zhen W, Zhou K, Gilbert E, Liu D. Baicalein Protects against Type 2 Diabetes via Promoting Islet ß-Cell Function in Obese Diabetic Mice. Int J Endocrinol 2014; 2014: 846742 [PMID: 25147566 DOI: 10.1155/2014/846742]
102. Gao M, Ma Y, Liu D. Rutin suppresses palmitic acids-triggered inflammation in macrophages and blocks high fat diet-induced obesity and fatty liver in mice. Pharm Res 2013; 30: 2940-2950 [PMID: 23783345 DOI: 10.1007/s11095-013-1125-1]
103. Zhang ZF, Fan SH, Zheng YL, Lu J, Wu DM, Shan Q, Hu B. Troxerutin improves hepatic lipid homeostasis by restoring NAD(+)-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice. Biochem Pharmacol 2014; 91: 74-86 [PMID: 25026599 DOI: 10.1016/j.bcp.2014.07.002]
104. Liu Y, Fu X, Lan N, Li S, Zhang J, Wang S, Li C, Shang Y, Huang T, Zhang L. Luteolin protects against high fat diet-induced cognitive deficits in obesity mice. Behav Brain Res 2014; 267: 178-188 [PMID: 24667364 DOI: 10.1016/j.bbr.2014.02.040]
105. Liu Q, Wang CY, Liu Z, Ma XS, He YH, Chen SS, Bai XY. Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-?/p38 MAPK signaling. Pharm Biol 2014; 52: 1085-1093 [PMID: 24618007 DOI: 10.3109/13880209.2013.877491]
106. Susutlertpanya W, Werawatganon D, Siriviriyakul P, Klaikeaw N. Genistein Attenuates Nonalcoholic Steatohepatitis and Increases Hepatic PPAR? in a Rat Model. Evid Based Complement Alternat Med 2015; 2015: 509057 [PMID: 26246839 DOI: 10.1155/2015/509057]
107. Zhang YB, Yan JD, Yang SQ, Guo JP, Zhang X, Sun XX, Na XL, Dai SC. Maternal Genistein Intake Can Reduce Body Weight in Male Offspring. Biomed Environ Sci 2015; 28: 769-772 [PMID: 26582099 DOI: 10.3967/bes2015.107]
108. Loguercio C, Andreone P, Brisc C, Brisc MC, Bugianesi E, Chiaramonte M, Cursaro C, Danila M, de Sio I, Floreani A, Freni MA, Grieco A, Groppo M, Lazzari R, Lobello S, Lorefice E, Margotti M, Miele L, Milani S, Okolicsanyi L, Palasciano G, Portincasa P, Saltarelli P, Smedile A, Somalvico F, Spadaro A, Sporea I, Sorrentino P, Vecchione R, Tuccillo C, Del Vecchio Blanco C, Federico A. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial.Free Radic Biol Med 2012; 52: 1658-1665 [PMID: 22343419 DOI: 10.1016/j.freerad]
109. Zhang Y, Gu M, Cai W, Yu L, Feng L, Zhang L, Zang Q, Wang Y, Wang D, Chen H, Tong Q, Ji G, Huang C. Dietary component isorhamnetin is a PPAR? Antagonist and ameliorates metabolic disorders induced by diet or leptin deficiency. Sci Rep 2016; 6: 19288 [PMID: 26775807 DOI: 10.1038/srep19288]
110. Zhang HJ, Zhang XF, Ma ZM, Pan LL, Chen Z, Han HW, Han CK, Zhuang XJ, Lu Y, Li XJ, Yang SY, Li XY. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. J Hepatol 2013; 59: 557-562 [PMID: 23665283 DOI: 10.1016/j.jhep.2013.04.030]
111. Wang D, Yan J, Chen J, Wu W, Zhu X, Wang Y. Naringin Improves Neuronal Insulin Signaling, Brain Mitochondrial Function, and Cognitive Function in High-Fat Diet-Induced Obese Mice. Cell Mol Neurobiol 2015; 35: 1061-1071 [PMID: 25939427 DOI: 10.1007/s10571-015-0201-y]
112. Lee H, Bae S, Kim K, Kim W, Chung SI, Yang Y, Yoon Y. Shikonin inhibits adipogenesis by modulation of the WNT/ß-catenin pathway. Life Sci 2011; 88: 294-301 [PMID: 21146546 DOI: 10.1016/j.lfs.2010.12.004]
113. Hoek-van den Hil EF, van Schothorst EM, van der Stelt I, Swarts HJ, van Vliet M, Amolo T, Vervoort JJ, Venema D, Hollman PC, Rietjens IM, Keijer J. Direct comparison of metabolic health effects of the flavonoids quercetin, hesperetin, epicatechin, apigenin and anthocyanins in high-fat-diet-fed mice. Genes Nutr 2015; 10: 469 [PMID: 26022682 DOI: 10.1007/s12263-015-0469-z]
114. Alkhalidy H, Moore W, Zhang Y, McMillan R, Wang A, Ali M, Suh KS, Zhen W, Cheng Z, Jia Z, Hulver M, Liu D. Small Molecule Kaempferol Promotes Insulin Sensitivity and Preserved Pancreatic ß -Cell Mass in Middle-Aged Obese Diabetic Mice. J Diabetes Res 2015; 2015: 532984 [PMID: 26064984 DOI: 10.1155/2015/532984]
115. Choi HN, Kang MJ, Lee SJ, Kim JI. Ameliorative effect of myricetin on insulin resistance in mice fed a high-fat, high-sucrose diet. Nutr Res Pract 2014; 8: 544-549 [PMID: 25324935 DOI: 10.4162/nrp.2014.8.5.544]
116. Sang H, Yuan N, Yao S, Li F, Wang J, Fang Y, Qin S. Inhibitory effect of the combination therapy of simvastatin and pinocembrin on atherosclerosis in ApoE-deficient mice. Lipids Health Dis 2012; 11: 166 [PMID: 23216643 DOI: 10.1186/1476-511X-11-166]
117. Faghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. Nutr Res 2014; 34: 837-843 [PMID: 25311610 DOI: 10.1016/j.nutres.2014.09.005]
118. Peluso I, Manafikhi H, Reggi R, Palmery M. Effects of red wine on postprandial stress: Potential implication in non-alcoholic fatty liver disease development. Eur J Nutr 2015; 54: 497-507 [PMID: 25772634 DOI: 10.1007/s00394-015-0877-2]
119. Frémont L. Biological effects of resveratrol. Life Sci 2000; 66: 663-673 [PMID: 10680575]
120. Bertelli AA, Das DK. Grapes, wines, resveratrol, and heart health. J Cardiovasc Pharmacol 2009; 54: 468-476 [PMID: 19770673 DOI: 10.1097/FJC.0b013e3181bfaff3]
121. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006; 127: 1109-1122 [PMID: 17112576]
122. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444: 337-342 [PMID: 17086191]
123. Shang J, Chen LL, Xiao FX, Sun H, Ding HC, Xiao H. Resveratrol improves non-alcoholic fatty liver disease by activating AMPactivated protein kinase. Acta Pharmacol Sin 2008; 29: 698-706 [PMID: 18501116 DOI: 10.1111/j.1745-7254.2008.00807.x]
124. Jeon BT, Jeong EA, Shin HJ, Lee Y, Lee DH, Kim HJ, Kang SS, Cho GJ, Choi WS, Roh GS. Resveratrol attenuates obesityassociated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes 2012; 61: 1444-1454 [PMID: 22362175 DOI: 10.2337/db11-1498]
125. Cho IJ, Ahn JY, Kim S, Choi MS, Ha TY. Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters. Biochem Biophys Res Commun 2008; 367: 190-194 [PMID: 18166149 DOI: 10.1016/j.bbrc.2007.12.140]
126. Gómez-Zorita S, Fernández-Quintela A, Macarulla MT, Aguirre L, Hijona E, Bujanda L, Milagro F, Martínez JA, Portillo MP. Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress. Br J Nutr 2012; 107: 202-210 [PMID: 21733326 DOI: 10.1017/S0007114511002753]
127. Alberdi G, Rodríguez VM, Macarulla MT, Miranda J, Churruca I, Portillo MP. Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet. Nutrition 2013; 29: 562-567 [PMID: 23274094 DOI: 10.1016/j.nut.2012.09.011]
128. Bagul PK, Middela H, Matapally S, Padiya R, Bastia T, Madhusudana K, Reddy BR, Chakravarty S, Banerjee SK. Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats. Pharmacol Res 2012; 66: 260-268 [PMID: 22627169 DOI: 10.1016/j.phrs.2012.05.003]
129. Qiao Y, Sun J, Xia S, Tang X, Shi Y, Le G. Effects of resveratrol on gut microbiota and fat storage in a mouse model with highfat- induced obesity. Food Funct 2014; 5: 1241-1249 [PMID: 24722352 DOI: 10.1039/c3fo60630a]
130. Chachay VS, Macdonald GA, Martin JH, Whitehead JP, O'Moore- Sullivan TM, Lee P, Franklin M, Klein K, Taylor PJ, Ferguson M, Coombes JS, Thomas GP, Cowin GJ, Kirkpatrick CM, Prins JB, Hickman IJ. Resveratrol does not benefit patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2014; 12: 2092-2103. e1-6 [PMID: 24582567 DOI: 10.1016/j.cgh.2014.02.024]
131. Noorafshan A, Ashkani-Esfahani S. A review of therapeutic effects of curcumin. Curr Pharm Des 2013; 19: 2032-2046 [PMID: 23116311]
132. Pan MH, Lai CS, Tsai ML, Ho CT. Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds. Mol Nutr Food Res 2014; 58: 147-171 [PMID: 24302567 DOI: 10.1002/mnfr.201300522]
133. Leclercq IA, Farrell GC, Sempoux C, dela Peña A, Horsmans Y. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice. J Hepatol 2004; 41: 926-934 [PMID: 15582125]
134. Vizzutti F, Provenzano A, Galastri S, Milani S, Delogu W, Novo E, Caligiuri A, Zamara E, Arena U, Laffi G, Parola M, Pinzani M, Marra F. Curcumin limits the fibrogenic evolution of experimental steatohepatitis. Lab Invest 2010; 90: 104-115 [PMID: 19901911 DOI: 10.1038/labinvest.2009.112]
135. Kuzu N, Bahcecioglu IH, Dagli AF, Ozercan IH, Ustündag B, Sahin K. Epigallocatechin gallate attenuates experimental nonalcoholic steatohepatitis induced by high fat diet. J Gastroenterol Hepatol 2008; 23: E465-e470 [PMID: 17683497]
136. Wang YC, Kong WZ, Jin QM, Chen J, Dong L. Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis. World J Gastroenterol 2015; 21: 10104-10112 [PMID: 26401075 DOI: 10.3748/wjg.v21.i35.10104]
137. Panchal SK, Ward L, Brown L. Ellagic acid attenuates highcarbohydrate, high-fat diet-induced metabolic syndrome in rats. Eur J Nutr 2013; 52: 559-568 [PMID: 22538930 DOI: 10.1007/s00394-012-0358-9]
138. Guo H, Xia M, Zou T, Ling W, Zhong R, Zhang W. Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1. J Nutr Biochem 2012; 23: 349-360 [PMID: 21543211 DOI: 10.1016/j.jnutbio.2010.12.013]
139. Tori M. Terpenoid Composition and Base Sequences of Ligularia virgaurea (Asteraceae) Grown in the Hengduan Mountain Area in China and a Comment on Drawing Structures. Chem Pharm Bull (Tokyo) 2016; 64: 193-206 [PMID: 26936046 DOI: 10.1248/cpb. c15-00878]
140. Arendt P, Pollier J, Callewaert N, Goossens A. Synthetic biology for production of natural and new-to-nature terpenoids in photosynthetic organisms. Plant J 2016; Epub ahead of print [PMID: 26867713 DOI: 10.1111/tpj.13138]
141. Choi YJ, Park SY, Kim JY, Won KC, Kim BR, Son JK, Lee SH, Kim YW. Combined treatment of betulinic acid, a PTP1B inhibitor, with Orthosiphon stamineus extract decreases body weight in highfat- fed mice. J Med Food 2013; 16: 2-8 [PMID: 23256448 DOI: 10.1089/jmf.2012.2384]
142. de Melo CL, Queiroz MG, Arruda Filho AC, Rodrigues AM, de Sousa DF, Almeida JG, Pessoa OD, Silveira ER, Menezes DB, Melo TS, Santos FA, Rao VS. Betulinic acid, a natural pentacyclic triterpenoid, prevents abdominal fat accumulation in mice fed a high-fat diet. J Agric Food Chem 2009; 57: 8776-8781 [PMID: 19754196 DOI: 10.1021/jf900768w]
143. Quan HY, Kim do Y, Kim SJ, Jo HK, Kim GW, Chung SH. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway. Biochem Pharmacol 2013; 85: 1330-1340 [PMID: 23435355 DOI: 10.1016/j.bcp.2013.02.007]
144. Jia Y, Kim S, Kim J, Kim B, Wu C, Lee JH, Jun HJ, Kim N, Lee D, Lee SJ. Ursolic acid improves lipid and glucose metabolism in high-fat-fed C57BL/6J mice by activating peroxisome proliferatoractivated receptor alpha and hepatic autophagy. Mol Nutr Food Res 2015; 59: 344-354 [PMID: 25418615 DOI: 10.1002/mnfr.201400399]
145. Wang CH, Wang ZT, Bligh SW, White KN, White CJ. Pharmacokinetics and tissue distribution of gentiopicroside following oral and intravenous administration in mice. Eur J Drug Metab Pharmacokinet 2004; 29: 199-203 [PMID: 15537172]
146. Kim KE, Ko KH, Heo RW, Yi CO, Shin HJ, Kim JY, Park JH, Nam S, Kim H, Roh GS. Artemisia annua Leaf Extract Attenuates Hepatic Steatosis and Inflammation in High-Fat Diet-Fed Mice. J Med Food 2016; 19: 290-299 [PMID: 26741655 DOI: 10.1089/jmf.2015.3527]
147. Li J, Wang RF, Yang L, Wang ZT. [Structure and biological action on cardiovascular systems of saponins from Panax notoginseng]. Zhongguo Zhong Yao Zazhi 2015; 40: 3480-3487 [PMID: 26978992]
148. Liu X, Yu JL, Liu M, Shu JC, Huang HL. Research progress of bioactivity of steroidal saponins in recent ten years. Zhongguo Zhong Yao Zazhi 2015; 40: 2518-2523 [PMID: 26697672]
149. Zhang ZY, Wu JP, Gao BB, Ren HT, Liu YL, Li XR, Li KP, Xu QM, Yang SL. Two new 28-nor-oleanane-type triterpene saponins from roots of Camellia oleifera and their cytotoxic activity. J Asian Nat Prod Res 2016; 18: 669-676 [PMID: 26982333]
150. Yin LH, Xu LN, Wang XN, Lu BN, Liu YT, Peng JY. An Economical method for isolation of dioscin from Dioscorea nipponica Makino by HSCCC coupled with ELSD, and a computer-aided UNIFAC mathematical model. Chromatographia 2009; 71: 15-23 [DOI: 10.1365/s10337-009-1407-2]
151. Hsieh MJ, Tsai TL, Hsieh YS, Wang CJ, Chiou HL. Dioscininduced autophagy mitigates cell apoptosis through modulation of PI3K/Akt and ERK and JNK signaling pathways in human lung cancer cell lines. Arch Toxicol 2013; 87: 1927-1937 [PMID: 23552851 DOI: 10.1007/s00204-013-]
152. Li H, Huang W, Wen Y, Gong G, Zhao Q, Yu G. Anti-thrombotic activity and chemical characterization of steroidal saponins from Dioscorea zingiberensis C.H. Wright. Fitoterapia 2010; 81: 1147-1156 [PMID: 20659537 DOI: 10.1016/j.fitote.2010.07.016]
153. Li M, Han X, Yu B. Synthesis of monomethylated dioscin derivatives and their antitumor activities. Carbohydr Res 2003; 338: 117-121 [PMID: 12526835]
154. Liu M, Xu L, Yin L, Qi Y, Xu Y, Han X, Zhao Y, Sun H, Yao J, Lin Y, Liu K, Peng J. Potent effects of dioscin against obesity in mice. Sci Rep 2015; 5: 7973 [PMID: 25609476 DOI: 10.1038/srep07973]
155. Shen L, Xiong Y, Wang DQ, Howles P, Basford JE, Wang J, Xiong YQ, Hui DY, Woods SC, Liu M. Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats. J Lipid Res 2013; 54: 1430-1438 [PMID: 23434611 DOI: 10.1194/jlr.M035907]
156. Yu H, Zhen J, Yang Y, Gu J, Wu S, Liu Q. Ginsenoside Rg1 ameliorates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress-induced apoptosis in a streptozotocin-induced diabetes rat model. J Cell Mol Med 2016; 20: 623-631 [PMID: 26869403 DOI: 10.1111/jcmm.12739]
157. Wang T, Choi RC, Li J, Bi CW, Ran W, Chen X, Dong TT, Bi K, Tsim KW. Trillin, a steroidal saponin isolated from the rhizomes of Dioscorea nipponica, exerts protective effects against hyperlipidemia and oxidative stress. J Ethnopharmacol 2012; 139: 214-220 [PMID: 22100563 DOI: 10.1016/j.jep.2011.11.001]
158. Stegelmeier BL, Brown AW, Welch KD. Safety concerns of herbal products and traditional Chinese herbal medicines: Dehydropyrrolizidine alkaloids and aristolochic acid. J Appl Toxicol 2015; 35: 1433-1437 [PMID: 26152912 DOI: 10.1002/jat.3192]
159. Kukula-Koch W, Koch W, Angelis A, Halabalaki M, Aligiannis N. Application of pH-zone refining hydrostatic countercurrent chromatography (hCCC) for the recovery of antioxidant phenolics and the isolation of alkaloids from Siberian barberry herb. Food Chem 2016; 203: 394-401 [PMID: 26948630 DOI: 10.1016/j.foodchem.2016.02.096]
160. Zhang J, Cao H, Zhang B, Cao H, Xu X, Ruan H, Yi T, Tan L, Qu R, Song G, Wang B, Hu T. Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling. J Cell Mol Med 2013; 17: 1484-1493 [PMID: 24015932 DOI: 10.1111/jcmm.12119]
161. Zhang H, Wei J, Xue R, Wu JD, Zhao W, Wang ZZ, Wang SK, Zhou ZX, Song DQ, Wang YM, Pan HN, Kong WJ, Jiang JD. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism 2010; 59: 285-292 [PMID: 19800084 DOI: 10.1016/j.metabol.2009.07.029]
162. Zhou L, Wang X, Yang Y, Wu L, Li F, Zhang R, Yuan G, Wang N, Chen M, Ning G. Berberine attenuates cAMP-induced lipolysis via reducing the inhibition of phosphodiesterase in 3T3-L1 adipocytes. Biochim Biophys Acta 2011; 1812: 527-535 [PMID: 20969954 DOI: 10.1016/j.bbadis.2010.10.001]
163. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, Wang S, Wu J, Wang Y, Li Z, Liu J, Jiang JD. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004; 10: 1344-1351 [PMID: 15531889]
164. Yuan X, Wang J, Tang X, Li Y, Xia P, Gao X. Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles. J Transl Med 2015; 13: 24 [PMID: 25623289 DOI: 10.1186/s12967-015-0383-6]
165. Zhang Y, Wang S, Li Y, Xiao Z, Hu Z, Zhang J. Sophocarpine and matrine inhibit the production of TNF-alpha and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice. Int Immunopharmacol 2008; 8: 1767-1772 [PMID: 18775799 DOI: 10.1016/j.intimp.2008.08.008]
166. Kim SJ, Lee SJ, Lee S, Chae S, Han MD, Mar W, Nam KW. Rutecarpine ameliorates bodyweight gain through the inhibition of orexigenic neuropeptides NPY and AgRP in mice. Biochem Biophys Res Commun 2009; 389: 437-442 [PMID: 19732749 DOI: 10.1016/j.bbrc.2009.08.161]
167. Shi L, Shi L, Zhang H, Hu Z, Wang C, Zhang D, Song G. Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-A activation. Mol Med Rep 2013; 8: 439-445 [PMID: 23754536 DOI: 10.3892/mmr.2013.1512]
168. Kwan HY, Niu X, Dai W, Tong T, Chao X, Su T, Chan CL, Lee KC, Fu X, Yi H, Yu H, Li T, Tse AK, Fong WF, Pan SY, Lu A, Yu ZL. Lipidomic-based investigation into the regulatory effect of Schisandrin B on palmitic acid level in non-alcoholic steatotic livers. Sci Rep 2015; 5: 9114 [PMID: 25766252 DOI: 10.1038/srep09114]
169. Lee JH, Jung JY, Jang EJ, Jegal KH, Moon SY, Ku SK, Kang SH, Cho IJ, Park SJ, Lee JR, Zhao RJ, Kim SC, Kim YW. Combination of honokiol and magnolol inhibits hepatic steatosis through AMPK-SREBP-1c pathway. Exp Biol Med (Maywood) 2015; 240: 508-518 [PMID: 25125496 DOI: 10.1177/1535370214547123]
170. Zhang Y, Fan S, Hu N, Gu M, Chu C, Li Y, Lu X, Huang C. Rhein Reduces Fat Weight in db/db Mouse and Prevents Diet-Induced Obesity in C57Bl/6 Mouse through the Inhibition of PPAR? Signaling. PPAR Res 2012; 2012: 374936 [PMID: 23049539 DOI: 10.1155/2012/374936]
171. Li J, Ding L, Song B, Xiao X, Qi M, Yang Q, Yang Q, Tang X, Wang Z, Yang L. Emodin improves lipid and glucose metabolism in high fat diet-induced obese mice through regulating SREBP pathway. Eur J Pharmacol 2016; 770: 99-109 [PMID: 26626587 DOI: 10.1016/j.ejphar.2015.11.045]